Vitamin D2 high dose supplementation
Pro Research Analysisby 
Searched over 200M research papers
High-Dose Vitamin D2 Supplementation: Effects on Serum Levels and Safety
A meta-analysis of randomized controlled trials shows that high-dose vitamin D2 supplementation significantly increases total vitamin D, 25(OH)D2, and 1,25(OH)D concentrations in the blood, especially at doses above 2000 IU/day, in older adults, and in those with low baseline vitamin D levels. However, it also decreases 25(OH)D3 concentrations, suggesting a shift in vitamin D metabolites with D2 supplementation. The effects are more pronounced with higher doses and shorter durations of supplementation, but patient characteristics and baseline vitamin D status should be considered when choosing dosing regimens .
Long-term high-dose vitamin D supplementation (up to 10,000 IU/day) is generally safe in healthy adults, with mild and transient hypercalcemia and increased rates of hypercalciuria observed at higher doses. Serious adverse events are rare, and most side effects resolve without intervention . Similarly, a study in African American men with chronic disease found no increase in serious adverse events, such as hospitalizations, with high-dose vitamin D supplementation over a year .
Clinical Outcomes of High-Dose Vitamin D2 Supplementation
Multiple Sclerosis
In patients with relapsing-remitting multiple sclerosis (RRMS), high-dose vitamin D2 supplementation (targeting serum 25OHD 130–175 nM) did not reduce MRI lesions or improve clinical outcomes compared to low-dose supplementation (1,000 IU/day). In fact, there were more relapses and higher disability scores in the high-dose group, indicating no therapeutic advantage and potential risks with high-dose D2 in this population .
Lactation and Infant Health
For lactating women, high-dose vitamin D2 supplementation (1600–3600 IU/day) safely increased vitamin D status in both mothers and nursing infants, with higher doses (up to 4000 IU/day) providing greater improvements. Standard recommendations of 400 IU/day are insufficient to maintain adequate vitamin D levels in mothers and infants, especially with limited sun exposure. High-dose supplementation can help prevent hypovitaminosis D in both groups .
Diabetes and Diabetic Neuropathy
In people with prediabetes, moderate to high doses of vitamin D supplementation (≥1000 IU/day) significantly reduced the risk of developing type 2 diabetes, while lower doses did not show benefit . In patients with type 2 diabetes and peripheral neuropathy, high-dose cholecalciferol (40,000 IU/week) improved neuropathy symptoms, microcirculation, and inflammatory markers, while lower doses (5,000 IU/week) had no effect .
Infections and Immune Function
High-dose vitamin D supplementation in children did not reduce the incidence of upper respiratory tract infections but did lower the odds of influenza/cold, cough, and fever. No effect was seen on more serious infections or hospitalizations. These findings are based on a limited number of trials and should be interpreted with caution . In adults with COVID-19 and vitamin D deficiency, high-dose cholecalciferol (60,000 IU/day for 7 days) increased the rate of viral clearance and reduced fibrinogen levels, suggesting a potential benefit in viral infections .
Falls and Fractures
Monthly high-dose vitamin D supplementation (100,000 IU/month) in older adults did not prevent falls or non-vertebral fractures compared to placebo, indicating no benefit for musculoskeletal outcomes in a generally healthy population .
Conclusion
High-dose vitamin D2 supplementation effectively raises serum vitamin D levels and is generally safe for most adults, with only mild and transient side effects. Clinical benefits depend on the population and health outcome: high doses may help prevent diabetes in prediabetic individuals, improve vitamin D status in lactating women and infants, and reduce some infection symptoms, but do not benefit multiple sclerosis, falls, or fractures, and may carry risks in certain groups. Careful consideration of dose, duration, and patient characteristics is essential for optimal use of high-dose vitamin D2 supplementation Santulli2011Hollis2004Onochie2016+7 MORE.
Sources and full results
Most relevant research papers on this topic
A Randomized Trial of High-Dose Vitamin D2 in Relapsing-remitting Multiple Sclerosis
High-dose vitamin D2 supplementation did not show a therapeutic advantage over low-dose supplementation in reducing MRI lesions in patients with relapsing-remitting multiple sclerosis.
High-Dose Vitamin D2 Supplementation for 1 Year Does not Cause Serious Adverse Events Such as Emergency Room Visits and Hospitalizations in African American Men with a High Burden of Chronic Disease.
High-dose vitamin D2 supplementation for 1 year does not cause serious adverse events like emergency room visits and hospitalizations in African American men with a high burden of chronic disease.
DOI